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ABSTRACT 
The Effects of Tryptophan Metabolites on Virulence of Salmonella Typhimurium. (May 2015) 
 
Michael Li 
Department of Chemical Engineering 
Texas A&M University 
 
Research Advisor: Dr. Arul Jayaraman 
Department of Chemical Engineering 
 
Salmonella is a foodborne pathogen that invades the human gastrointestinal (GI) tract from the 
intestinal lumen by targeting intestinal epithelial cells (IECs). It is able to breach the protective 
IEC barrier with the aid of needle-like complexes encoded by a cluster of genes known as the 
Salmonella pathogenicity island 1 (SPI1). The influence that molecules in the GI tract have on 
pathogenicity and virulence is not yet fully understood because of the complexity and abundance 
of metabolites present in the GI microenvironment. One source of metabolites is the amino acid 
tryptophan, which is transformed into indole and other indole-like metabolites by the microbiota 
in the GI tract. Roles for many of the gut metabolites are still unknown. Previous research in the 
Jayaraman laboratory has shown that indole, a tryptophan metabolite, decreases the virulence of 
Salmonella. In this project, we studied the effects of tryptophan derivatives which are present in 
the GI tract – indole-acetic acid, tryptamine, indole-pyruvic acid, and hydroxyindole – on the 
virulence of Salmonella. The motility of the pathogen in response to the different tryptophan 
derivatives was determined using the swimming motility assay (SMA). The expression of SPI1 
genes was measured using the β-galactosidase reporter assay as a measure of virulence. The 
results of the SMA show that the tryptophan derivatives tested do not affect the motility of 
Salmonella significantly, whereas indole decreases motility by 40%. The effect of these 
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metabolites on the expression of SPI1 genes, hilA and invF, was observed to be much less 
compared with that of indole. We therefore conclude that not all tryptophan metabolites present 
in the GI tract decrease the virulence of Salmonella Typhimurium to the same extent. Further 
research needs to be done to determine the roles of these tryptophan derivatives as well as 
several other molecules present in the GI tract microenvironment.  
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NOMENCLATURE 
 
DMSO   dimethyl sulfoxide 
HI   hydroxyindole 
I   indole 
IAA    indole-3-acetic acid 
IPA   indole-3-pyruvic acid 
IEC    intestinal epithelial cell 
LB    lysogeny broth 
MCT   microcentrifuge tubes 
OD420nm  optical density at 420nm wavelength of light 
OD600nm  optical density at 600nm wavelength of light 
ONPG   ortho-nitrophenyl-β-galactoside 
SCV   Salmonella-containing vacuole 
SDS   sodium dodecyl sulfate 
SPI    Salmonella pathogenicity island 
T3SS   type 3 secretion system 
TA   tryptamine 
tet20   20 µg of tetracycline/ mL of 70% ethanol 
WT   wild type 
X-gal   5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
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CHAPTER I 
INTRODUCTION 
 
The human gut is densely populated with microorganisms. It contains up to 10
14
 prokaryotic 
cells, which is 10 times more than the number of human body cells (Staib and Fuchs). The large 
number of metabolites produced in the gut is due to the constant metabolism of dietary 
compounds (i.e. carbon and nitrogen sources) by microbiota (Staib and Fuchs). A healthy 
balance of gut microbiota is vital for the maintenance of a strong immune system. The 
microbiota drain most of the nutrients in the gut before the pathogens can use them to colonize 
(Staib and Fuchs). Food particles entering the intestine are digested by gut microbiota and then, 
are converted into essential nutrients and other metabolic by-products. Metabolites can be 
absorbed into the intestinal lumen or can influence the activity of other gut microbes. Roles for 
many gut metabolites and their influence on pathogens are still unknown due to the complexity 
and abundance of metabolites present in the GI microenvironment.  
 
Salmonella is a foodborne pathogen that will come into contact with gut metabolites upon oral 
ingestion with food particles. It invades the human gastrointestinal tract by targeting IECs. It 
uses a T3SS characterized by the formation of a needlelike complex responsible for invasion 
(Hegazy and Hensel). This complex injects proteins that alter the IEC cytoskeleton and 
manipulate the cell processes to provide favorable conditions for Salmonella growth (Basel). 
Salmonella can affect other types of cells downstream and eventually cause gastroenteritis 
(Hansen-Wester and Hensel). In the US alone, it has been associated with approximately 40,000 
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reported cases and 400 deaths per year. The actual number of infections is estimated to be more 
than thirty times greater than the number of reported cases (CDC).  
 
The SPI is the chromosomal region where T3SS genes are clustered. One loci, SPI1, contains 
more than 25 genes responsible for the formation of the needlelike complex (Hansen-Wester and 
Hensel). Here, we studied the effect of metabolites on the expression of two SPI1 genes — hilA 
and invF. They are both transcriptional factors that influence the expression of other SPI1 genes 
involved in the formation of T3SS needle proteins. hilA is known to be the master regulator of 
SPI1 and invF is downstream of it. Figure 1 below shows how Salmonella invades IECs (Hegazy 
and Hensel). 
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Figure 1. Key events in Salmonella pathogenesis. (A) Within the chromosome of Salmonella enterica, several 
virulence clusters known as Salmonella pathogenicity islands (SPI) are present. In particular, SPI1 and SPI2 play 
important roles in invasion and intracellular survival, respectively. (B) Genes within SPI1 and SPI2 
of Salmonella encode two distinct virulence-associated T3SS that are important for different phases of 
pathogenesis. (C) Orally ingested Salmonella survive in the low pH of the stomach, enter the small intestine and 
invade epithelial cells. Upon invasion, Salmonella SPI1-T3SS delivers its effector proteins across the host cell 
plasma membrane, which leads to temporal reorganization of the host cell actin cytoskeleton and induces uptake of 
the bacteria by means of macropinocytosis and plays an important role in Salmonella-induced inflammatory 
responses. Salmonella remains in a specialized phagosome, the SCV, where multifunctional virulence system SPI2-
T3SS plays its role in Salmonella survival inside the SCV and inducing systematic 
responses. (D) Salmonella preferentially enters microfold cells, which transport them to the lymphoid cells (T and B 
cells) in the underlying Peyer's patches. Nontyphoidal Salmonella strains induce an early local inflammatory 
response, which results in the infiltration of PMNs into the intestinal lumen and diarrhea. On the other 
hand, Salmonella serotypes that are associated with systemic illness enter intestinal macrophages and disseminate 
throughout the reticuloendothelial system. (Hegazy and Hensel) 
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As mentioned previously, gut metabolites can be absorbed into the intestinal lumen or influence 
the activity of other microbes. In the case of Salmonella food poisoning, metabolites that arise 
from the breakdown of food particles can affect the Salmonella invasion process. One main 
source of metabolites comes from the amino acid, tryptophan, a major constituent of the human 
diet. It can be catalyzed into indole and other indole-like metabolites by either the host or gut 
microbiota. Indole-3-pyruvic acid, tryptamine, 5-hydroxy-L-tryptophan, and indole have been 
detected in caecum luminal contents of mice (Sridharan et al.).  This project focuses the 
following tryptophan metabolites: indole-3- acetic acid, indole-3-pyruvic acid, tryptamine, and 
5-hydroxyindole. These metabolites, shown in Figure 2, were tested to determine their effects on 
virulence of Salmonella Typhimurium ATCC 14028s.  
 
Figure 2. Tryptophan can be catalyzed by the host or microbiota to produce a range of other metabolites. These 
metabolites can also under chemical reactions with other metabolites to form indole derivatives. 
9 
 
Previous studies in the Jayaraman group have shown that indole, a tryptophan metabolite, 
decreases Salmonella virulence by downregulation of SPI1 genes (Kohli). The motility of 
Salmonella in response to the tryptophan metabolites in Figure 2 were tested using the swimming 
motility assay. The expression of SPI1 genes, hilA and invF, were measured using the β-
galactosidase reporter assay as a measure of virulence. Studying these tryptophan metabolites 
will help determine their roles they play in the Salmonella invasion process within in the GI 
tract. 
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CHAPTER II 
METHODS 
 
Part A. Swimming Motility Assay 
A WT strain of S. Typhimurium 14028s was grown on an LB agar plate. The strain was 
incubated overnight at 37°C. A single isolated colony of the WT strain was inoculated in 5 mL 
of LB media. The tube was incubated overnight for 16 hours at 37°C, 250 rpm. The OD600nm was 
recorded by diluting sample of the overnight culture in 1:10 total (100 µL cell culture + 900 µL 
LB media). The overnight culture was diluted to an OD600nm of 0.05 in fresh 5 mL LB media. 
The culture tubes were incubated at 37°C, 250 rpm , and the incubation was stopped once the 
culture turbidity was about 1.0 (approximately 2 hours).  
 
Swimming motility agar plates (25 mL per plate) were prepared with the composition (1% 
tryptone, 0.25% NaCl, and 0.3% agar, with or without additives to be tested) The 6 conditions 
tested were as follows: 
1. DMSO (solvent control) 
2. 1 mM IAA 
3. 1 mM TA 
4. 1 mM IPA 
5. 1 mM HI 
6. 1 mM I 
1 M stock of the treatment chemical was added to SMA media to achieve a final concentration of 
1 mM prior to pouring. 1 µL of the culture was spotted on each plate, which were incubated 
11 
 
upright at 37°C. The diameters of the motility halos were measured after 8 hours using Vernier 
calipers. (Bansal et al.) 
 
Part B. β-galactosidase Reporter Assay for SPI1 Gene Expression 
SPI1 gene reporter strains were used to determine the effect of tryptophan metabolites on 
virulence gene expression. A lacZ gene was fused to both the hilA and invF genes to form 
hilA::lacZ and invF::lacZ  (Altier, Suyemoto and Lawhon). The hilA and invF reporter strains 
were grown on LB plates containing tetracycline (tet) and X-gal at a concentration of 20 µg/mL 
and 40 µg/mL, respectively. Overnight cultures were started from a single colony in a tube 
containing 5 mL of LB media (1% tryptone, 0.5% NaCl, and 0.5% yeast extract) containing tet20 
and 1 mM of respective signals at 37°C with shaking.  
 
The OD600nm was recorded by diluting a sample of the overnight culture in 1:4 total (250 µL cell 
culture + 750 µL media). For the β-galactosidase assay, the following chemicals were added in a 
2 mL microcentrifuge tube (MCT): 900 µL Z buffer, 100 µL of cell suspension, 5 µL SDS, and 
10 µL chloroform. The tubes were vortexed for 10 seconds and then placed on ice. The 
procedure was repeated for the blank by using 100 µL of LB media in place of the cell culture. 
The tubes were incubated at 28°C for 5 minutes. The reaction was started by adding 200 µL of 4 
mg/mL ONPG substrate. Once the solution turned yellow, the reaction was stopped by adding 
500 µL of 1 M Na2CO3. The total time of reaction in minutes was recorded. The tubes were 
centrifuged for 2 minutes at 10,000 g, 4°C and then placed on ice. The OD420nm was measured 
for the supernatant, and the Miller β-galactosidase units were calculated by Equation 1.  
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The fold decrease of Miller β-galactosidase units produced for each treatment was compared 
with that of DMSO. Fold decrease was calculated by Equation 2.  
 
             
       β                          
       β                                
                       (2) 
 
The assay was performed for three biological replicates (Miller).  
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CHAPTER III 
RESULTS 
 
Part A. Swimming Motility Assay 
Swimming motility halos form due to outward migration of bacteria from the center where they 
were spotted. For each condition — DMSO (solvent control), IAA, TA, IPA, HI, and I  — plate 
images were taken after eight hours of incubation as shown in Figure 3a-f below.  
 
   
a.          b.            c. 
 
   
d.           e.           f. 
Figure 3. Swimming motility assay plate images representative of each treatment. The outermost halo diameter was 
recorded. a.) DMSO control, b) 1 mM IAA, c) 1 mM TA, d) 1 mM IPA, e) 1 mM HI, and f) 1 mM I. 
 
Diameters of the motility halos formed by the swimming bacteria were recorded in millimeters 
as shown in Table 1 and then plotted in Figure 4. Indole decreased halo diameters by 40% 
compared to the solvent control whereas the change was not significant for other treatments.  
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Table 1. Swimming motility assay halo diameters (mm) 
Replicate DMSO IPA IAA TA HI I 
1 35.39 38.91 37.63 35.98 32.08 22.14 
2 32.72 36.51 34.26 34.54 31.50 20.31 
3 29.19 32.75 31.34 31.01 27.84 18.24 
Average 32.43 36.06 34.41 33.84 30.47 20.23 
Std. Dev. 3.11 3.10 3.15 2.56 2.30 1.95 
 
 
Figure 4. Average halo diameters for treatment plotted with error bars of one standard deviation. (Student T-tests, 
*p<0.05) 
 
 
 Part B. β-galactosidase Reporter Assay for SPI1 Gene Expression 
Miller β-galactosidase units are a measure of gene expression. They were recorded for the 
reporter strains under the following treatments: DMSO (solvent control), IAA, TA, IPA, HI, and 
I.   
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Miller β-galactosidase units produced by each treatment were recorded for the hilA::lacZ as 
shown in Table 2 and then plotted in Figure 5. The same was done for the invF::lacZ strain in  
Table 3 and then plotted in Figure 6.  
 
Table 2. Miller β-galactosidase units produced by hilA::lacZ strain 
Replicate DMSO TA HI IAA IPA I 
1 1586 1288 762 767 495 37 
2 1774 1798 1318 1401 710 90 
3 2118 2009 1608 817 414 53 
Average 1826 1699 1229 995 540 60 
Std. Dev. 270 371 430 353 153 27 
Fold Decrease — 1.1 1.5 1.8 3.4 30.4 
 
 
Figure 5. Miller β-galactosidase units for each treatment for the hilA::lacZ strain were plotted along with error bars of 
one standard deviation. (Student T-tests, *p<0.05) 
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Table 3. Miller β-galactosidase units produced by invF::lacZ strain 
Replicate DMSO TA HI IAA IPA I 
1 1240 1131 625 451 399 11 
2 1393 1178 750 520 363 9 
3 848 — — 447 321 4 
Average  1316 1154 688 486 381 10 
Std. Dev. 243 19 51 34 33 3 
Fold Decrease — 1.1 1.9 2.7 3.5 128.2 
 
 
Figure 6. Miller β-galactosidase units for each treatment for the hilA::lacZ strain were plotted with error bars of one 
standard deviation. (Student T-tests, *p<0.05) (only two replicates were tested for TA and HI) 
 
Summary of Results 
The results of the swimming motility assay and β-galactosidase assay are summarized below 
in Table 4. 
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Table 4. Summary of results for swimming motility assay and β-galactosidase assay 
Assay Observations 
Swimming Motility Assay 
Diameter changes were not significant for all 
treatments except for I, which resulted in a 40% 
decrease 
β-galactosidase Assay 
hilA 
Decrease in Miller β-galactosidase units were 
significant for all treatments except for TA and HI 
invF 
Decrease in Miller β-galactosidase units were 
significant for all treatments except for TA 
Overall 
All metabolites had a lower fold decrease compared 
with that of indole 
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CHAPTER IV 
CONCLUSIONS 
 
The swimming motility assay showed that for all treatments except for indole, the change in 
motility was not significant. The β-galactosidase assay showed that the decrease in hilA gene 
expression was significant for indole-3-acectic acid, indole-3-pyruvic acid, and indole 
treatments. Decrease in invF gene expression was significant for hydroxyindole, indole-3-acetic 
acid, indole-3-pyruvic acid, and indole treatments. However, the small magnitudes of fold 
decrease in gene expression for all treatments were all incomparable to the large magnitude of 
fold decrease observed for indole. Therefore, we can conclude that not all tryptophan metabolites 
have the same effect on Salmonella virulence. The metabolites that caused a significant decrease 
in gene expression did not behave the same for the motility assay, suggesting a mutiple-pathway 
interaction between metabolites and Salmonella.  
 
Future studies include testing other tryptophan derivatives as well as other gut metabolites in 
varying concentrations. The relationship between the chemical structures of metabolites and their 
effect on Salmonella virulence can also be explored. The pharmaceutical industry can potentially 
use the results of future studies to develop medical drugs for preventing Salmonella food 
poisoning.  
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